Brief: Xoma Corp Entered Into Commercial Payment Purchase Agreement With Affitech Research AS
Oct 7 (Reuters) - XOMA Corp XOMA.O :
* XOMA CORP - ON OCTO 6,, UNIT ENTERED INTO COMMERCIAL
PAYMENT
PURCHASE AGREEMENT WITH AFFITECH RESEARCH AS
* XOMA CORP - XOMA (US) LLC HAS PURCHASED FUTURE STREAM OF
COMMERCIAL PAYMENT RIGHTS TO ROCHE'S FARICIMAB FROM AFFITECH FOR
$6 MILLION
* XOMA CORP - XOMA (US) LLC MAY PAY UP TO AN ADDITIONAL $20
MILLION TO AFFITECH BASED UPON ACHIEVEMENT OF CERTAIN REGULATORY
AND SALES MILESTONES
Further company coverage: XOMA.O
Recent news on Xoma Royalty
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM